Jublia (efinaconazole) completely cures toenail fungus in about 15 to 18 percent of people after 48 weeks of daily use. That number sounds low, but it makes Jublia one of the more effective topical options available. The gap between expectation and reality with toenail fungus treatments is wide, so understanding what these cure rates actually mean helps you set realistic goals.
Complete Cure vs. Mycological Cure
Jublia’s effectiveness depends on how you define “cure,” and the FDA tracks two different measures. Complete cure means the nail looks entirely normal (zero percent affected) and lab tests confirm the fungus is gone. Mycological cure is a lower bar: the fungus is eliminated in lab testing, but the nail may still show some discoloration or thickening from prior damage.
In two large clinical trials involving over 1,200 patients, Jublia achieved complete cure rates of 17.8% and 15.2% after 48 weeks of treatment, with results measured at week 52. Mycological cure rates were considerably higher: 55.2% and 53.4%. So roughly half of people using Jublia successfully killed the fungus, even though the nail hadn’t fully grown out to look normal yet. Patients using a placebo solution achieved complete cure rates of only 3.3% to 5.5%, confirming that the drug itself is doing real work.
The practical takeaway: if you use Jublia consistently for a full year, you have roughly a coin-flip chance of clearing the infection itself. But a cosmetically perfect nail takes longer, because toenails grow slowly and damaged nail needs to fully grow out and be replaced.
How Jublia Compares to Other Topicals
Among topical nail fungus treatments, Jublia has the strongest cure rates. Tavaborole (Kerydin), another prescription topical, achieved complete cure rates of only 6.5% and 9.1% in its clinical trials. Ciclopirox (Penlac), an older nail lacquer, managed 5.5% to 8.5%. Jublia’s 15 to 18% complete cure rate is roughly double to triple what these alternatives deliver.
That said, none of these topical treatments come close to oral medications. Continuous terbinafine (taken daily for 12 to 16 weeks) and itraconazole (daily for 12 weeks) produce significantly higher odds of clearing the fungus compared to any topical. A large network analysis of 26 clinical trials involving over 8,000 patients confirmed this gap. If your priority is the highest chance of cure, oral treatment is more effective.
The trade-off people often assume is that oral antifungals carry more side effects, since they’re processed through the liver. Interestingly, the same analysis found no significant difference in overall adverse event rates between oral and topical therapies. The risks are different in nature (liver monitoring with oral drugs versus skin irritation with topicals), but the overall frequency of problems was comparable. Your doctor will weigh factors like other medications you take, liver health, and severity of infection when recommending one route over the other.
What 48 Weeks of Treatment Looks Like
Jublia is applied once daily to affected toenails for 48 weeks, just under a full year. You brush the solution directly onto the nail using a built-in applicator. Results were formally assessed at week 52, four weeks after treatment ended, giving the nail a brief window to continue improving.
Toenails grow roughly 1.5 millimeters per month, meaning a full big toenail takes 12 to 18 months to completely replace itself. Even if Jublia kills the fungus within the first few months, you won’t see a fully clear nail until the damaged portion grows out entirely. This is why the mycological cure rate (over 50%) is so much higher than the complete cure rate (15 to 18%) at the one-year mark. Many people who technically succeeded at killing the fungus simply hadn’t grown out enough new nail yet.
Consistency matters. Missing applications or stopping early reduces your chances. The clinical trials measured people who used the product as directed for the full 48-week course.
Side Effects
Jublia is well tolerated overall. The FDA lists no contraindications, meaning there are no conditions that absolutely prevent its use. The most common side effects are localized to the application site: skin irritation (dermatitis), small blisters (vesicles), pain at the site, and ingrown toenails. These occurred in a small percentage of users and were generally mild.
Because Jublia is applied to the nail and surrounding skin rather than taken by mouth, it avoids the systemic concerns associated with oral antifungals, like liver strain or drug interactions. This makes it a reasonable option for people who can’t take oral medications or prefer to avoid them. It’s approved for patients aged 6 and older.
Who Gets the Best Results
Jublia works best when the fungal infection is mild to moderate, meaning the fungus affects a limited portion of the nail. The clinical trials enrolled patients with infections involving up to 50% of the nail surface, with no involvement of the growth center at the base of the nail (called the lunula). If more than half the nail is affected, or if the infection has reached the nail matrix where new nail is produced, topical treatment alone is less likely to succeed.
Thicker nails also present a challenge. Jublia needs to penetrate through the nail plate to reach the fungus underneath, and heavily thickened nails create a physical barrier. Some dermatologists recommend filing down or debriding thickened nail before applying topical treatments to improve penetration, though this wasn’t a formal part of the clinical trials.
If your infection is severe, involves multiple nails, or has been present for many years, oral therapy (or a combination of oral and topical) is more likely to produce a cure. Jublia is strongest as a standalone treatment for earlier-stage infections on one or two toenails.
The Cost Factor
Jublia is a brand-name prescription medication, and its cost is a real consideration given the 48-week treatment course. Without insurance, a single bottle can run several hundred dollars, and you’ll need multiple bottles over the full treatment period. Some insurance plans cover it, others don’t, and prior authorization requirements are common. Generic efinaconazole has become available, which may lower the price depending on your pharmacy and coverage. Given the modest complete cure rates, the cost-per-cure calculation is something worth discussing with your provider, especially if an oral option with higher efficacy is medically appropriate for you.